Department of Clinical Chemistry
University of Turku

Back to the main page of the Department of Clinical Chemistry

Julkaisut 2001 / Publications in 2001

  1. Ahokoski O, Irjala K, Taalikka M, *Manninen P, *Halonen K, *Kangas L, Salminen E, Huupponen R, Scheinin H. Pharmacokinetics of finrozole (MPV-2213ad), a novel selective aromatase inhibitor, in healthy men. Br J Clin Pharmacol 2001:52(6):702-704. [C]
  2. *Arkkila PET, Koskinen PJ, Kantola I M, Rönnemaa T, Seppänen E, Viikari J S. Diabetic complications are associated with liver enzyme activities in people with type 1 diabetes. Diabetes Res Clin Pract 2001(52):113-118. [C]
  3. *Dunder U, Mononen I. Human leukocyte glycosylasparaginase: cell-to-cell transfer and properties in correction of aspartylglycosaminuria. FEBS Lett 2001:499:77-81. [C]
  4. *Grönholm M, Leino A, Saarimies J, *Lillsunde P. Huumepikatestien luotettavuuden ja käyttökelpoisuuden arviointi virtsa- ja sylkinäytteistä. Suomen Lääkäril 2001:56(8):871-875. [c]
  5. *Grönholm M, Leino A, Saarimies J, *Lillsunde P. Huumepikatestit. Kirjassa: Irti Huumeista ry, Keskusrikospoliisi, Opetushallitus, Suomen Vakuutusyhtiöiden Keskusliitto, Stakes: Suomi ja huumeet - tietopaketti huumeista, 3. p. 2001, s. 126-129. [i]
  6. Grönroos JM, Grönroos P. Diagnosis of acute appendicitis. Radiology 2001:219(1):297-298. [E]
  7. Heikkinen J, Möttönen M, Pulkki K, Lassila O, Alanen A. Cytokine levels in midtrimester amniotic fluid in normal pregnancy and in the prediction of pre-eclampsia. Scand J Immunol 2001:53(3):310-314. [C]
  8. *Hujakka H, *Koistinen V, *Eerikäinen P, *Kuronen I, Mononen I, *Parviainen M, *Lundkvist Å, *Vaheri A, *Närvänen A, *Vapalahti O. New immunochromatographic rapid test for diagnosis of acute Puumala virus infection. J Clin Microbiol 2001:39(6):2146-2150. [C]
  9. Järvisalo M, *Jartti L, Näntö-Salonen K, Irjala K, Rönnemaa T, Hartiala J, *Celermajer D, Raitakari O. Increased aortic intima-media thickness. A marker of preclinical atherosclerosis in high-risk children. Circulation 2001(104):2943-2947. [C]
  10. Kailajärvi M, Ahokoski O, *Virtanen A, Salminen E, Irjala K. Early effects of 5-fluorouracil, epirubicin and cyclophosphamide therapy on common laboratory tests. Anticancer Res 2001:21:2867-2872. [C]
  11. Kalliomäki M, Salminen S, *Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001:357(9262):1076-1079. [C]
  12. Kankuri M, Pelliniemi T-T, Pyrhönen S, Nikkanen V, Helenius H, Salminen E. Feasibility of prolonged use of interferon-alpha in metastatic kidney carcinoma - a phase II study. Cancer 2001:92(4):761-767. [C]
  13. Leino A, Saarimies J, *Grönholm M, *Lillsunde P. Comparison of eight commercial on-site screening devices for drugs-of-abuse testing. Scand J Clin Lab Invest 2001:61:325-332. [C]
  14. Pajulo OT, Pulkki KJ, Lertola KK, Alanen MS, Reunanen MS, Virtanen RV, Mattila-Vuori AI, Viljanto JA. Hyaluronic acid in incision wound fluid: a clinical study with the Cellstick device in children. Wound Repair Regen 2001:9(3):200-204. [C]
  15. *Piironen T, Nurmi M, Irjala K, Heinonen O, *Lilja H, *Lövgren T, *Pettersson K. Measurement of circulating forms of prostate-specific antigen in whole blood immediately after venipuncture: implications for point-of-care testing. Clin Chem 2001:47(4):703-711. [C]
  16. Polo-Kantola P, *Rauhala E, Erkkola R, Irjala K, Polo O. Estrogen replacement therapy and nocturnal periodic limb movements: a randomized controlled trial. Obstet Gynecol 2001:97(4):548-554. [C]
  17. Raitakari M, *Lähdeniemi M, Pelliniemi T-T. ID-GelStation -automaatin koestus TYKS:n verikeskuksessa. Kliin Lab 2001(4):49-53. [e]
  18. *Rantamäki M, *Krahe R, *Paetau A, *Cormand B, Mononen I, *Udd B. Adult-onset autosomal recessive ataxia with thalamic lesions in a Finnish family. Neurology 2001:57:1043-1049. [C]
  19. Rantonen T, Kääpä P, Jalonen J, Ekblad U, Peltola O, Välimäki I, Kero P. Antenatal magnesium sulphate exposure is associated with prolonged parathyroid hormone suppression in preterm neonates. Acta Paediatr 2001(90):278-281. [C]
  20. Räty R, *Virtanen A, Koskinen P, Anttila L, *Laitinen P, *Tiitinen A, Ekblad U. Maternal serum beta-hCG levels in screening for Down syndrome are higher in singleton pregnancies achieved with ovulation induction and intrauterine insemination than in spontaneous singleton pregnancies. Fertil Steril 2001:76(5):1075-1077. [C]
  21. Salminen E, Kankuri M, Nuutila J, Lilius EM, Pelliniemi T-T. Modulation of IgG and complement receptor expression of phagocytes in kidney cancer patients during treatment with interferon-alpha. Anticancer Res 2001:21:2049-2056. [C]
  22. Sumiala S, Tuominen J, Irjala K, *Mäenpää J. Serum total renin after tubal sterilization. Clin Chem Lab Med 2001:39(7):615-617. [C]
  23. Suominen P, Irjala K. Health-related decision limits rather than reference limits to guide the use of ferritin measurements. Clin Biochem 2001:34:345-346. [E]
  24. Suominen P, *Virtanen A, Lehtonen-Veromaa M, Heinonen O J, Salmi Toivo T, Alanen Markku, Möttönen T, Rajamäki A, Irjala K. Regression-based reference limitis for serum transferrin receptor in children 6 months to 16 years of age. Clin Chem 2001(47):935-937. [C]
  25. *Sze DM-Y, *Giesajtis G, *Brown RD, Raitakari M, *Gibson J, *Ho J, *Baxter AG. Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8+CD57+CD28- compartment. Blood 2001:98(9):2817-2827. [C]
  26. Vasankari T, Ahotupa M, Toikka J, Mikkola J, Irjala K, Pasanen P, Neuvonen K, Raitakari O, Viikari J. Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy. Atherosclerosis 2001(155):403-412. [C]
  27. Vasankari T, Ahotupa M, Toikka Jyri, Mikkola Jorma , Irjala K, Raitakari O, Viikari JSA. Increased levels of cirulating oxidized LDL in men with coronary atherosclerosis. Atherosclerosis 2001:155:403-412. [C]